BRIDGEWATER, N.J., Jan. 29, 2025 (GLOBE NEWSWIRE) -- (“Vyluma”), a biopharmaceutical company advancing novel treatments for ...
It wasn’t the cancer that got him in the end, it was the heart. I miss him a huge lot. He was a legend, the funniest guy I ...
Developments include low-dose atropine eye drops and LASIK procedures. The global myopia and presbyopia treatment market is ...